Protocol · Women's Health
Intrauterine Growth Restriction (IUGR) Prevention and Support Protocol
Omega-3 Fatty Acids (Fish Oil) and L-Arginine are the core of this stack, with 6 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Intrauterine Growth Restriction (IUGR) Prevention and Support.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
8 supplements · 1 graded
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file |
|---|---|---|---|---|
| Primary stackThe core of this protocol | ||||
| Omega-3 Fatty Acids (Fish Oil) | Amount listed: 1–2 g DHA+EPA daily (ensure low mercury source) | Supports placental blood flow and fetal development; may reduce risk of growth restriction
| Grade B for Infant Birth Weight2,302 people | |
| L-Arginine | Amount listed: 3–6 g daily in divided doses | Nitric oxide precursor that supports placental blood flow; may improve fetal growth | Not graded yet | |
| Supporting stackListed as additions to the core | ||||
| Folate/Folic Acid | Amount listed: 800–1,000 mcg daily (methylfolate for MTHFR variants) | Essential for fetal development; adequate levels support healthy placental function | Not graded yet | |
| Vitamin D | Amount listed: 2,000–4,000 IU daily (based on levels) | Deficiency associated with increased IUGR risk; supports placental function | Not graded yet | |
| Iron | Amount listed: 27–60 mg elemental iron daily (based on hemoglobin/ferritin) | Prevents anemia which impairs oxygen delivery to fetus; supports healthy fetal growth | Not graded yet | |
| Zinc | Amount listed: 15–25 mg daily | Essential for fetal growth and development; deficiency linked to IUGR | Not graded yet | |
| Coenzyme Q10 | Amount listed: 100–200 mg daily | Supports mitochondrial function and placental energy metabolism | Not graded yet | |
| Low-Dose Aspirin | Amount listed: 81–162 mg daily starting before 16 weeks (as prescribed) | Improves placental blood flow; recommended for high-risk pregnancies (prescription) | Not graded yet | |
How this protocol works
In plain language
Intrauterine Growth Restriction (IUGR) or Fetal Growth Restriction (FGR) occurs when a baby in the womb doesn't grow as expected, typically defined as estimated fetal weight below the 10th percentile for gestational age. It can be caused by problems with the placenta (most common), maternal health conditions (hypertension, preeclampsia), infections, genetic factors, or lifestyle factors like smoking. IUGR increases risks for stillbirth, premature birth, and health problems for the baby.
CRITICAL: IUGR requires close medical monitoring throughout pregnancy. Diagnosis is made by ultrasound measuring fetal size and assessing placental blood flow (Doppler studies). Management depends on cause, severity, and gestational age - may include increased monitoring, early delivery if fetal distress, or corticosteroids for lung development if preterm delivery anticipated. Address modifiable risk factors: STOP SMOKING, control blood pressure, treat any underlying conditions. These supplements may support placental function and fetal growth but do not replace medical management. Work closely with your maternal-fetal medicine specialist.
Omega-3 Fatty Acids (Fish Oil)* support placental blood flow and fetal development. Meta-analyses suggest fish oil supplementation may reduce the risk of growth restriction and preterm birth.
L-Arginine* is a nitric oxide precursor that supports blood vessel relaxation and blood flow. Studies show it may improve fetal growth in pregnancies with IUGR, likely by improving placental blood flow.
Folate* is essential for fetal development and healthy placental function. Adequate folate intake throughout pregnancy supports growth.
Vitamin D* deficiency has been associated with increased IUGR risk. Maintaining adequate levels supports placental function and fetal bone development.
Iron* supplementation prevents maternal anemia, which can impair oxygen delivery to the fetus and contribute to growth restriction.
Zinc* is essential for fetal growth and development. Deficiency has been linked to IUGR and poor birth outcomes.
Coenzyme Q10* supports mitochondrial function and energy production in the placenta.
Low-Dose Aspirin* (prescription) is recommended for women at high risk of preeclampsia and IUGR. It improves placental blood flow and significantly reduces these complications when started early in pregnancy.
Expected timeline: Preventive supplements should be started early in pregnancy (ideally preconception). L-arginine effects on blood flow may be seen within weeks. Fetal growth is monitored by serial ultrasounds.